Holger Wesche - Net Worth and Insider Trading

Holger Wesche Net Worth

The estimated net worth of Holger Wesche is at least $121,608 dollars as of 2024-05-26. Holger Wesche is the Chief Scientific Officer of Harpoon Therapeutics Inc and owns about 5,285 shares of Harpoon Therapeutics Inc (HARP) stock worth over $121,608. Details can be seen in Holger Wesche's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Holger Wesche has not made any transactions after 2021-01-04 and currently still holds the listed stock(s).

Transaction Summary of Holger Wesche

To

Holger Wesche Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Holger Wesche owns 1 companies in total, including Harpoon Therapeutics Inc (HARP) .

Click here to see the complete history of Holger Wesche’s form 4 insider trades.

Insider Ownership Summary of Holger Wesche

Ticker Comapny Transaction Date Type of Owner
HARP Harpoon Therapeutics Inc 2021-01-04 Chief Scientific Officer

Holger Wesche Latest Holdings Summary

Holger Wesche currently owns a total of 1 stock. Holger Wesche owns 5,285 shares of Harpoon Therapeutics Inc (HARP) as of January 4, 2021, with a value of $121,608.

Latest Holdings of Holger Wesche

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HARP Harpoon Therapeutics Inc 2021-01-04 5,285 23.01 121,608

Holding Weightings of Holger Wesche


Holger Wesche Form 4 Trading Tracker

According to the SEC Form 4 filings, Holger Wesche has made a total of 7 transactions in Harpoon Therapeutics Inc (HARP) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Harpoon Therapeutics Inc is the sale of 1,000 shares on January 4, 2021, which brought Holger Wesche around $183,800.

Insider Trading History of Holger Wesche

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Holger Wesche Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Holger Wesche Ownership Network

Ownership Network List of Holger Wesche

No Data

Ownership Network Relation of Holger Wesche


Holger Wesche Owned Company Details

What does Harpoon Therapeutics Inc do?

Who are the key executives at Harpoon Therapeutics Inc?

Holger Wesche is the Chief Scientific Officer of Harpoon Therapeutics Inc. Other key executives at Harpoon Therapeutics Inc include 10 percent owner Vijay K Lathi , Chief Medical Officer Luke Nathaniel Walker , and Principal Fin. & Acctng Ofc. Frank J Lanza .

Harpoon Therapeutics Inc (HARP) Insider Trades Summary

Over the past 18 months, Holger Wesche made no insider transaction in Harpoon Therapeutics Inc (HARP). Other recent insider transactions involving Harpoon Therapeutics Inc (HARP) include a net purchase of 21,397,205 shares made by Merck & Co., Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Harpoon Therapeutics Inc (HARP) in total and bought 21,397,205 shares, with a net purchase of 21,397,205 shares. During the past 18 months, 0 shares of Harpoon Therapeutics Inc (HARP) were sold and 21,397,205 shares were bought by its insiders, resulting in a net purchase of 21,397,205 shares.

Harpoon Therapeutics Inc (HARP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Harpoon Therapeutics Inc Insider Transactions

No Available Data

Holger Wesche Mailing Address

Above is the net worth, insider trading, and ownership report for Holger Wesche. You might contact Holger Wesche via mailing address: C/o Harpoon Therapeutics, Inc., 4000 Shoreline Court, Suite 250, South San Francisco Ca 94080.

Discussions on Holger Wesche

No discussions yet.